{"hands_on_practices": [{"introduction": "The journey of a patient through a PET/CT scan begins with a crucial first step: the administration of the radiopharmaceutical. Ensuring patient safety while obtaining high-quality diagnostic images requires a careful calculation of the injected activity and the resulting radiation exposure. This foundational practice [@problem_id:5062267] walks through the straightforward but essential process of determining the appropriate dose of ${}^{18}\\text{F}$-FDG based on patient weight and estimating the effective dose, linking the principles of nuclear medicine to direct clinical application.", "problem": "A patient with head and neck squamous cell carcinoma is scheduled for a diagnostic study using Positron Emission Tomography (PET) with Fluorine-18 fluorodeoxyglucose (FDG). The study follows a linear mass-based dosing guideline and uses a well-established dosimetric conversion factor. Assume the following:\n\n- The patient’s body mass is $80 \\,\\mathrm{kg}$.\n- The administered activity is determined by a linear dosing guideline of $3 \\,\\mathrm{MBq/kg}$.\n- The effective dose per unit administered activity for Fluorine-18 fluorodeoxyglucose is $0.019 \\,\\mathrm{mSv/MBq}$.\n\nUsing fundamental definitions that activity is measured in Becquerel as disintegrations per second and that, under the linearity assumption, both the administered activity and effective dose scale proportionally with patient mass and administered activity, respectively, compute:\n\n1. The injected activity for this patient.\n2. The corresponding effective dose.\n\nExpress the injected activity in megabecquerel (MBq) and the effective dose in millisievert (mSv). Round each final value to three significant figures. Provide both values together in the order: injected activity (MBq), effective dose (mSv).", "solution": "The problem is determined to be valid as it is scientifically grounded in the principles of nuclear medicine and medical physics, well-posed with sufficient and consistent data, and objectively stated. The calculations required are straightforward applications of definitions provided.\n\nThe solution proceeds by first calculating the total injected activity and then using that result to calculate the corresponding effective dose.\n\nLet $M$ be the patient's body mass, $G_A$ be the linear dosing guideline, and $k_E$ be the effective dose per unit administered activity (the dosimetric conversion factor). The given values are:\n- $M = 80 \\,\\mathrm{kg}$\n- $G_A = 3 \\,\\mathrm{MBq/kg}$\n- $k_E = 0.019 \\,\\mathrm{mSv/MBq}$\n\n**1. Calculation of the Injected Activity**\n\nThe total injected activity, which we will denote as $A$, is determined by the linear mass-based dosing guideline. This implies a direct proportionality between activity and mass, expressed by the equation:\n$$A = M \\times G_A$$\nSubstituting the provided numerical values into this equation:\n$$A = (80 \\,\\mathrm{kg}) \\times (3 \\,\\frac{\\mathrm{MBq}}{\\mathrm{kg}})$$\nThe units of mass ($\\mathrm{kg}$) cancel out, leaving the activity in units of megabecquerel ($\\mathrm{MBq}$), as required.\n$$A = 240 \\,\\mathrm{MBq}$$\nThe problem specifies that the final value should be rounded to three significant figures. The calculated value $240$ can be written in scientific notation as $2.40 \\times 10^2$, which confirms it has three significant figures. Thus, no further rounding is necessary.\n\n**2. Calculation of the Effective Dose**\n\nThe effective dose, which we will denote as $E$, is stated to scale proportionally with the administered activity. The relationship is defined by the dosimetric conversion factor, $k_E$. The equation is:\n$$E = A \\times k_E$$\nUsing the previously calculated value for the activity, $A = 240 \\,\\mathrm{MBq}$, we can compute the effective dose:\n$$E = (240 \\,\\mathrm{MBq}) \\times (0.019 \\,\\frac{\\mathrm{mSv}}{\\mathrm{MBq}})$$\nThe units of activity ($\\mathrm{MBq}$) cancel, yielding the effective dose in units of millisievert ($\\mathrm{mSv}$), as required.\n$$E = 4.56 \\,\\mathrm{mSv}$$\nThis result, $4.56$, already contains three significant figures. Therefore, it meets the requirement of the problem statement without any modification.\n\nThe final results, in the requested order of injected activity (MBq) and effective dose (mSv), are $240$ and $4.56$ respectively.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n240 & 4.56\n\\end{pmatrix}\n}\n$$", "id": "5062267"}, {"introduction": "Once PET images are acquired, their true power in oncology lies in quantification—turning pictures into numbers. The Standardized Uptake Value ($SUV$) is the most common metric used to measure tumor metabolic activity, providing an objective way to assess disease. This exercise [@problem_id:5062319] delves into the calculation of both the weight-based $SUV$ and the lean body mass-based $SUL$, highlighting how these indices normalize tracer uptake and allow for standardized comparison across different patients and time points.", "problem": "A patient with head and neck squamous cell carcinoma undergoes Positron Emission Tomography (PET) with integrated Computed Tomography (CT) using ${}^{18}\\text{F}$-fluorodeoxyglucose (FDG). At $60$ minutes post-injection, quantitative image analysis reports a lesion activity concentration of $12 \\text{ kBq/mL}$. The net injected activity (after accounting for residuals) is $300 \\text{ MBq}$. The patient’s body weight is $70 \\text{ kg}$, and their Lean Body Mass (LBM) is $50 \\text{ kg}$. Assume standard oncologic PET quantification conventions and that soft tissue density is approximately that of water, so $1 \\text{ mL} \\approx 1 \\text{ g}$. Ignore partial-volume effects and any physiological or scanner-specific corrections beyond decay correction implicit in the reported concentration at $60$ minutes.\n\nStarting from the core definition that Standardized Uptake Value (SUV) and Standardized Uptake Value normalized by Lean body mass (SUL) quantify activity concentration relative to administered activity per unit mass, use physically consistent unit transformations to compute the SUV normalized by total body weight and the SUL normalized by LBM. Express both answers as dimensionless values and round to three significant figures. Provide the pair of values in the order: SUV (body weight) and SUL (lean body mass).", "solution": "The problem is valid as it is scientifically grounded in the principles of quantitative positron emission tomography (PET), provides a complete and consistent set of data typical for a clinical scenario, and is well-posed, leading to a unique solution.\n\nThe problem requires the calculation of two key metrics in PET imaging: the Standardized Uptake Value ($SUV$) normalized by total body weight, and the Standardized Uptake Value normalized by Lean Body Mass ($SUL$ or $SUV_{lbm}$).\n\nThe fundamental definition of $SUV$ is the ratio of the activity concentration in a region of interest (in this case, the lesion) to the total injected activity concentration if it were uniformly distributed throughout a given mass of the patient. The mass can be either the total body weight ($W$) or the lean body mass ($LBM$).\n\nLet $C_{lesion}$ be the activity concentration in the lesion, and let $A_{inj}$ be the net injected activity.\n\nThe formula for $SUV$ based on total body weight ($W$) is given by:\n$$ SUV = \\frac{C_{lesion}}{A_{inj} / W} $$\n\nThe formula for $SUL$ based on lean body mass ($LBM$) is given by:\n$$ SUL = \\frac{C_{lesion}}{A_{inj} / LBM} $$\n\nWe are given the following values:\n- Lesion activity concentration, $C_{lesion} = 12 \\, \\mathrm{kBq}/\\mathrm{mL}$.\n- Net injected activity, $A_{inj} = 300 \\, \\mathrm{MBq}$.\n- Patient’s body weight, $W = 70 \\, \\mathrm{kg}$.\n- Patient's Lean Body Mass, $LBM = 50 \\, \\mathrm{kg}$.\n\nTo ensure the resulting values are dimensionless, all quantities must be in a consistent system of units. We will convert activity to Becquerels ($Bq$) and mass to grams ($g$). The problem states we can assume the density of soft tissue is approximately that of water, so $1 \\, \\mathrm{mL} \\approx 1 \\, \\mathrm{g}$. This allows us to treat the concentration unit $\\mathrm{kBq}/\\mathrm{mL}$ as equivalent to $\\mathrm{kBq}/\\mathrm{g}$.\n\nFirst, we perform the unit conversions:\nThe lesion concentration is:\n$$ C_{lesion} = 12 \\, \\frac{\\mathrm{kBq}}{\\mathrm{mL}} = 12 \\times 10^3 \\, \\frac{\\mathrm{Bq}}{\\mathrm{mL}} \\approx 12 \\times 10^3 \\, \\frac{\\mathrm{Bq}}{\\mathrm{g}} $$\nThe injected activity is:\n$$ A_{inj} = 300 \\, \\mathrm{MBq} = 300 \\times 10^6 \\, \\mathrm{Bq} $$\nThe patient's body weight is:\n$$ W = 70 \\, \\mathrm{kg} = 70 \\times 10^3 \\, \\mathrm{g} $$\nThe patient's lean body mass is:\n$$ LBM = 50 \\, \\mathrm{kg} = 50 \\times 10^3 \\, \\mathrm{g} $$\n\nNow, we can calculate the $SUV$ based on total body weight:\n$$ SUV = \\frac{C_{lesion}}{A_{inj} / W} = \\frac{12 \\times 10^3 \\, \\mathrm{Bq}/\\mathrm{g}}{\\frac{300 \\times 10^6 \\, \\mathrm{Bq}}{70 \\times 10^3 \\, \\mathrm{g}}} = \\frac{(12 \\times 10^3) \\times (70 \\times 10^3)}{300 \\times 10^6} $$\n$$ SUV = \\frac{12 \\times 70 \\times 10^6}{300 \\times 10^6} = \\frac{840}{300} = 2.8 $$\nRounding to three significant figures, we get $SUV = 2.80$.\n\nNext, we calculate the $SUL$ based on lean body mass:\n$$ SUL = \\frac{C_{lesion}}{A_{inj} / LBM} = \\frac{12 \\times 10^3 \\, \\mathrm{Bq}/\\mathrm{g}}{\\frac{300 \\times 10^6 \\, \\mathrm{Bq}}{50 \\times 10^3 \\, \\mathrm{g}}} = \\frac{(12 \\times 10^3) \\times (50 \\times 10^3)}{300 \\times 10^6} $$\n$$ SUL = \\frac{12 \\times 50 \\times 10^6}{300 \\times 10^6} = \\frac{600}{300} = 2.0 $$\nRounding to three significant figures, we get $SUL = 2.00$.\n\nThe problem asks for the pair of values: $SUV$ (body weight) and $SUL$ (lean body mass). The resulting pair is $(2.80, 2.00)$.", "answer": "$$\\boxed{\\begin{pmatrix} 2.80 & 2.00 \\end{pmatrix}}$$", "id": "5062319"}, {"introduction": "While the $SUV$ provides a vital quantitative measure, its accuracy is fundamentally limited by the scanner's spatial resolution, especially for small lesions common in head and neck cancer. This phenomenon, known as the partial volume effect, can lead to a significant underestimation of true tumor uptake. This practice [@problem_id:5062262] explores the physics behind this effect and demonstrates how a recovery coefficient can be used to understand the relationship between the measured, apparent $SUV$ and the true, underlying biological activity.", "problem": "A patient with oropharyngeal carcinoma undergoes Positron Emission Tomography (PET) using Fluorodeoxyglucose, reconstructed on a clinical system whose Point Spread Function (PSF) can be modeled as a three-dimensional Gaussian with a Full Width at Half Maximum (FWHM) of $5 \\,\\mathrm{mm}$. Consider a metastatic level II cervical lymph node that is approximately spherical with diameter $8 \\,\\mathrm{mm}$ and has spatially uniform true activity concentration within its boundary. Assume that the Standardized Uptake Value (SUV) is dimensionless and proportional to the reconstructed activity concentration.\n\nUsing first principles, explain why limited spatial resolution produces partial volume effects that reduce the apparent SUV of small objects, relating this to convolution of the true activity distribution with the system PSF and to the concept of a recovery coefficient. The recovery coefficient (RC) is defined for a given object shape and size on a given system as the ratio of the measured to the true activity concentration. For this $8 \\,\\mathrm{mm}$ spherical node imaged with a $5 \\,\\mathrm{mm}$ FWHM system, an empirically determined recovery coefficient of $RC = 0.45$ is available.\n\nIf the node’s true standardized uptake value (that would be obtained with infinite spatial resolution and ideal reconstruction) is $12.0$, calculate the apparent measured SUV for this node on the described system. Express your final answer as a pure number and round to three significant figures.", "solution": "The problem requires an explanation of the partial volume effect and a calculation of the measured Standardized Uptake Value (SUV).\n\n**Explanation of the Partial Volume Effect**\n\nAn ideal imaging system would reproduce the true distribution of activity in an object with perfect fidelity. However, any real-world imaging system has limited spatial resolution, which causes a blurring effect. This is mathematically described by the convolution operation. Let $A_t(\\mathbf{r})$ be the true three-dimensional activity concentration distribution of the object, where $\\mathbf{r}$ is a position vector. Let $h(\\mathbf{r})$ be the system's Point Spread Function (PSF), which describes the blurred image of a point source of activity. The measured (or reconstructed) activity distribution, $A_m(\\mathbf{r})$, is the convolution of the true distribution with the PSF:\n$$\nA_m(\\mathbf{r}) = (A_t * h)(\\mathbf{r}) = \\int_{\\mathbb{R}^3} A_t(\\mathbf{r'}) h(\\mathbf{r} - \\mathbf{r'}) d^3\\mathbf{r'}\n$$\nIn this problem, the PSF, $h(\\mathbf{r})$, is a Gaussian function with a Full Width at Half Maximum (FWHM) of $5 \\,\\mathrm{mm}$. The FWHM is a measure of the extent of the blurring; a larger FWHM implies poorer spatial resolution and more blurring.\n\nThe true activity distribution, $A_t(\\mathbf{r})$, for the lymph node is described as a uniform concentration within an $8 \\,\\mathrm{mm}$ diameter sphere and zero outside. This is a spherical \"top-hat\" function. When this sharp-edged function is convolved with the blurring Gaussian PSF, the resulting measured distribution, $A_m(\\mathbf{r})$, is smeared out. This phenomenon is known as the Partial Volume Effect (PVE).\n\nPVE has two primary consequences for a small, hot object (like a tumor) in a cooler background:\n1.  **Spill-out**: Activity that is truly inside the object boundary is measured as if it were in the surrounding background. This reduces the measured activity concentration within the object.\n2.  **Spill-in**: Activity from the surrounding background is measured as if it were inside the object. For a hot object in a cold (zero-activity) background, this effect is negligible, but the effect of averaging the hot signal with the cold background within voxels at the object's edge is still present.\n\nDue to the dominant spill-out effect, the peak or average measured activity concentration, $A_m$, within the boundaries of the small sphere will be lower than the true activity concentration, $A_t$. The object will also appear larger and with fuzzier borders than it truly is.\n\nThe Recovery Coefficient (RC) is introduced to quantify this loss of signal. As defined in the problem, it is the ratio of the measured to the true activity concentration:\n$$\nRC = \\frac{A_{measured}}{A_{true}}\n$$\nThe value of $RC$ depends on the object's size and shape, and the system's spatial resolution (FWHM). For objects that are small relative to the FWHM (e.g., diameter $< 2 \\times$ FWHM), $RC$ is significantly less than $1$. As the object size increases, $RC$ approaches $1$, as the blurring becomes less significant relative to the object's volume. Here, the diameter ($8 \\,\\mathrm{mm}$) is only $1.6$ times the FWHM ($5 \\,\\mathrm{mm}$), so a substantial reduction in measured signal is expected, consistent with the given $RC=0.45$.\n\n**Calculation of the Apparent Measured SUV**\n\nThe problem states that SUV is proportional to the activity concentration. Let $C$ represent activity concentration. We can write this relationship as $SUV = k \\cdot C$, where $k$ is a proportionality constant that depends on factors like injected dose and patient weight, but is constant for a given scan.\n\nThe true SUV, $SUV_{true}$, corresponds to the true activity concentration, $C_{true}$:\n$$\nSUV_{true} = k \\cdot C_{true}\n$$\nThe apparent measured SUV, $SUV_{measured}$, corresponds to the measured activity concentration, $C_{measured}$:\n$$\nSUV_{measured} = k \\cdot C_{measured}\n$$\nThe Recovery Coefficient is defined in terms of concentrations:\n$$\nRC = \\frac{C_{measured}}{C_{true}}\n$$\nWe can express $RC$ in terms of SUV by taking the ratio of $SUV_{measured}$ to $SUV_{true}$:\n$$\n\\frac{SUV_{measured}}{SUV_{true}} = \\frac{k \\cdot C_{measured}}{k \\cdot C_{true}} = \\frac{C_{measured}}{C_{true}} = RC\n$$\nTherefore, the relationship $SUV_{measured} = RC \\cdot SUV_{true}$ holds.\n\nThe problem provides the following values:\n-   True SUV: $SUV_{true} = 12.0$\n-   Recovery Coefficient: $RC = 0.45$\n\nWe can now calculate the apparent measured SUV:\n$$\nSUV_{measured} = RC \\cdot SUV_{true} = 0.45 \\cdot 12.0\n$$\n$$\nSUV_{measured} = 5.4\n$$\nThe problem requires the answer to be expressed to three significant figures. To satisfy this, we write the result as $5.40$.\n\nThus, due to the partial volume effect caused by the system's limited spatial resolution, the lymph node with a true SUV of $12.0$ would have an apparent measured SUV of only $5.40$.", "answer": "$$\n\\boxed{5.40}\n$$", "id": "5062262"}]}